Drug intelligence / Profile preview

polihexanide + propamidine

Development stage
Unknown
Lead developer
SIFI
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

**Polihexanide + propamidine** is a combination of two small molecule antiseptics used topically in ophthalmology, primarily for the treatment of **Acanthamoeba keratitis**, a rare, sight-threatening corneal infection. Polihexanide (also called polyhexamethyl biguanide, PHMB) is a biguanide antiseptic that disrupts cytoplasmic membranes and damages genetic material of Acanthamoeba, leading to cell death. Propamidine is an aromatic diamidine compound that acts as an anti-amoebic and antibacterial agent by interfering with DNA function. This combination is not a licensed product but is widely used in clinical practice, typically prepared as PHMB 0.02% and propamidine 0.1% eye drops, and administered hourly initially, then tapered. Clinical studies have demonstrated its safety and efficacy, with favorable visual outcomes and a reduced need for corneal transplantation.

Other names
polihexanide 0.02% + propamidine 0.1%PHMB 0.02% + propamidine 0.1%polyhexamethyl biguanide + propamidinePHMB + propamidine
02

Targets

Acanthamoeba DNA phosphate backbone and chromosomes

Beyond the preview

Go deeper on polihexanide + propamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polihexanide + propamidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call